genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Coronavirus
Breathe In: Theravance Reports Positive Phase II Data for JAK Inhibitor
Cancer
The Life Oncolytic, with Stephen Russell
Synthetic Biology
Flush with Cash, Foresite Aims to Live Up to Its Name
OMICs
From Genomes to Drugs: An Interview with Vertex CSO David Altshuler
Gene Therapy
AI Gets Gene Therapy Over the Immunity Hump
News
Drug Discovery
Melanoma Resistance to Checkpoint Therapy Scrutinized with Perturb-CITE-Seq
News
Light-Controlled Clustering of Receptors Acts Like a Signal to Trigger Cellular…
Coronavirus
Five COVID-19 Projects at UCSD Receive $33 million from NIH
OMICs
Scientists Sequence 64 Human Genomes as New Reference for Genetic Diversity
OMICs
Changes in the Gut Microbiome Potentially Linked to Alzheimer’s
Insights
All
Trends for 2021
Trends for 2020
A-Lists
Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020
Bioprocessing
COVID-19 Increasing Risk of Cyberattacks for Digital Biopharma
Bioprocessing
Case Study: How to Accelerate COVID-19 Vaccine Development
Bioprocessing
Flexibility is Key to Advances in Biomanufacturing
A-Lists
A-Lists
Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Coronavirus
Breathe In: Theravance Reports Positive Phase II Data for JAK Inhibitor
Drug Discovery
Melanoma Resistance to Checkpoint Therapy Scrutinized with Perturb-CITE-Seq
OMICs
Scientists Sequence 64 Human Genomes as New Reference for Genetic Diversity
OMICs
Changes in the Gut Microbiome Potentially Linked to Alzheimer’s
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Liver Diseases
Liver Diseases
Most popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Liver Diseases
$20 Blood Test Could Contribute to “Global HBV Elimination”
Liver Diseases
BMS Withdraws Combination NDA, Vows to Pursue Daclatasvir Approval
Liver Diseases
Regulus Axing 60% of Workforce, Pauses Patient Recruitment for Lead Program
Liver Diseases
Gilead to Acquire Phenex’s FXR Program for Up-to-$470M
Liver Diseases
AstraZeneca Halts Development of Regulus NASH Candidate
Liver Diseases
FDA Gives Abbott a Thumbs-Up for Automated HBV Monitoring Test
Liver Diseases
Gilead’s Solvadi for Chronic Hepatitis C Wins FDA Approval
Liver Diseases
EHSI Forms JV to Evaluate a Regenerative Medicine Method
Liver Diseases
CRISPR Reverses Disease Symptoms in Living Animals for First Time
Liver Diseases
Dainippon Sumitomo Pays Intercept $15M for Phase III Liver Disease Drug
Liver Diseases
Vertex Grows HCV Pipeline with Purchase of ViroChem
Liver Diseases
PROTACs Developed with U. of Dundee Boost Boehringer Ingelheim’s Cancer Pipeline
Liver Diseases
FDA Clears Vertex’ Incivek as Combination Therapy for Chronic HCV Type...
Liver Diseases
FDA to Use Emulate’s Organ-on-a-Chip Technology for Toxicology Testing
Liver Diseases
NIH Blood Test Developed for Liver Cancer Screening
1
2
3
...
8
Page 1 of 8
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Phase III studies demonstrated that adding telaprevir to PEGinterferon and ribavirin significantly improves SVR rates.[© 4designersart - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/May24_2011_23183575_HepatitisVirus_FDAClearsVertexIncivekForHCV2441621606-324x160.jpg "FDA Clears Vertex’ Incivek as Combination Therapy for Chronic HCV Type 1")
